Reductase‐mediated metabolism of motexafin gadolinium (Xcytrin®) in rat and human liver subcellular fractions and purified enzyme preparations
- 1 March 2005
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 94 (3), 559-570
- https://doi.org/10.1002/jps.20274
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Motexafin gadolinium reacts with ascorbate to produce reactive oxygen speciesChemical Communications, 2002
- Lead-In Phase to Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation for Patients With Brain Metastases: Centralized Assessment of Magnetic Resonance Imaging, Neurocognitive, and Neurologic End PointsJournal of Clinical Oncology, 2002
- Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen speciesInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinium in Patients With Brain MetastasesJournal of Clinical Oncology, 2001
- Texaphyrins: Synthesis and Development of a Novel Class of Therapeutic AgentsPublished by Wiley ,2001
- In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- One-Electron Reduction and Oxidation Studies of the Radiation Sensitizer Gadolinium(III) Texaphyrin (PCI-0120) and Other Water Soluble MetallotexaphyrinsThe Journal of Physical Chemistry A, 1999
- Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Aminopyrine demethylase kinetic evidence for multiple microsomal activitiesBiochemical Pharmacology, 1970
- [111] Glucose-6-phosphataseMethods in Enzymology, 1966